References
  1. Berman BD. Neuroleptic malignant syndrome: a review for neurohospitalists. The Neurohospitalist . 2011;1(1):41-7.
  2. Nisijima K, Shioda K. A rare case of neuroleptic malignant syndrome without elevated serum creatine kinase. Neuropsychiatr Dis Treat . 2014; 10: 403.
  3. Desai D, Gupta K, Kumar R, Biswas A. Levosulpiride-induced neuroleptic malignant syndrome in rheumatoid arthritis. BMJ Case Rep . 2018
  4. Kaur U, Das P, Gambhir IS, Chakrabarti SS. L-type calcium channel blockers and a symptom complex mimicking de Melo-Souza’s syndrome.Neurol. Sci. 2019;40(5):1077-80.
Table 1 : Biochemical, hematological, and radiological investigations of the patient.
Supplementary table 1: Differential diagnoses of neuroleptic malignant syndrome and salient features.